bioAffinity Technologies (BIAF) Other Operating Expenses (2021 - 2026)

bioAffinity Technologies (BIAF) has reported Other Operating Expenses for 6 consecutive years, with -$2.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Operating Expenses fell 260.32% year-over-year to -$2.7 million; the TTM figure through Mar 2026 stood at $1.1 million (down 83.62% YoY), while the FY2025 annual figure was $5.4 million, down 21.32% from the prior year.
• Other Operating Expenses eased to -$2.7 million in Q1 2026 per BIAF's latest filing, from $1.3 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $1.9 million in Q4 2023 and bottomed at -$2.7 million in Q1 2026.
• Historically, Other Operating Expenses has averaged $710983.9 across 5 years, with a median of $1.2 million in 2025.
• Annual changes were most pronounced in 2023 — Other Operating Expenses surged 16273.59% — and 2026, when it sank 260.32%.
• bioAffinity Technologies' Other Operating Expenses stood at $11659.0 in 2022, then soared by 16273.59% to $1.9 million in 2023, then slipped by 3.44% to $1.8 million in 2024, then dropped by 28.47% to $1.3 million in 2025, then tumbled by 301.93% to -$2.7 million in 2026.
• Business Quant data shows BIAF's Other Operating Expenses at -$2.7 million in Q1 2026, $1.3 million in Q4 2025, and $1.2 million in Q3 2025.